CAPRICOR THERAPEUTICS, INC. (CAPR) Free cash flow 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$72.7MFY2025 · since FY2016: -$14.6M → -$72.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$72.7M | -76.7% |
| FY2024 | -$41.2M | -53.0% |
| FY2023 | -$26.9M | -1022.7% |
| FY2022 | $2.9M | +116.2% |
| FY2021 | -$18.0M | -69.8% |
| FY2020 | -$10.6M | -55.4% |
| FY2019 | -$6.8M | +51.9% |
| FY2018 | -$14.2M | +0.6% |
| FY2017 | -$14.3M | +2.6% |
| FY2016 | -$14.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice